Tomokazu Ishitobi

发表

Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia.

K. Chayama, K. Arihiro, S. Tazuma, 2008, Metabolism: clinical and experimental.

Efficacy of rosuvastatin for the treatment of non‐alcoholic steatohepatitis with dyslipidemia: An open‐label, pilot study

K. Chayama, K. Arihiro, H. Aikata, 2012, Hepatology research : the official journal of the Japan Society of Hepatology.

Eicosapentaenoic acid/arachidonic acid ratio as a possible link between non‐alcoholic fatty liver disease and cardiovascular disease

K. Chayama, K. Arihiro, H. Aikata, 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

Efficacy of probucol for the treatment of non‐alcoholic steatohepatitis with dyslipidemia: An open‐label pilot study

K. Chayama, K. Arihiro, H. Hyogo, 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH

K. Chayama, K. Arihiro, S. Yamagishi, 2010, Journal of Gastroenterology.

Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property.

K. Chayama, S. Yamagishi, H. Hyogo, 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Serum levels of pigment epithelium-derived factor (PEDF) are independently associated with procollagen III N-terminal peptide levels in patients with nonalcoholic fatty liver disease.

K. Chayama, S. Yamagishi, H. Hyogo, 2012, Clinical biochemistry.

Increased insulinogenic index is an independent determinant of nonalcoholic fatty liver disease activity score in patients with normal glucose tolerance.

K. Chayama, S. Yamagishi, H. Hyogo, 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Serum asymmetric dimethylarginine levels are independently associated with procollagen III N-terminal peptide in nonalcoholic fatty liver disease patients

K. Chayama, S. Yamagishi, S. Ueda, 2014, Clinical and Experimental Medicine.

Clinical usefulness of glucose tolerance test in nonalcoholic fatty liver disease patients without overt diabetes mellitus

K. Chayama, K. Arihiro, H. Hyogo, 2010 .

Elevated levels of serum advanced glycation end products in patients with non‐alcoholic steatohepatitis

K. Chayama, K. Arihiro, S. Tazuma, 2007, Journal of gastroenterology and hepatology.

A nuclear receptor-mediated choleretic action of fibrates is associated with enhanced canalicular membrane fluidity and transporter activity mediating bile acid-independent bile secretion.

K. Chayama, S. Tazuma, H. Hyogo, 2005, Journal of atherosclerosis and thrombosis.

Postprandial insulin secretion pattern is associated with histological severity in non‐alcoholic fatty liver disease patients without prior known diabetes mellitus

K. Chayama, K. Arihiro, H. Hyogo, 2011, Journal of gastroenterology and hepatology.

Real‐world efficacy of sofosbuvir plus velpatasvir therapy for patients with hepatitis C virus‐related decompensated cirrhosis

M. Imamura, K. Chayama, D. Miki, 2020, Hepatology research : the official journal of the Japan Society of Hepatology.

Hemobilia after laparoscopic cholecystectomy that was successfully treated conservatively: Case report

Tomokazu Ishitobi, Y. Miyata, K. Sumimoto, 2020, International journal of surgery case reports.

Efficacy of probucol for the treatment of non‐alcoholic steatohepatitis with dyslipidemia: An open‐label pilot study

K. Chayama, K. Arihiro, H. Hyogo, 2014, Hepatology research : the official journal of the Japan Society of Hepatology.